首页|正常和动脉粥样硬化大鼠体内银杏黄酮苷元药代动力学差异及相关机制研究

正常和动脉粥样硬化大鼠体内银杏黄酮苷元药代动力学差异及相关机制研究

扫码查看
比较正常和动脉粥样硬化(atherosclerosis,AS)大鼠口服银杏黄酮苷元(ginkgo flavone aglycone,GA)的药代动力学,以及探究产生差异的相关机制研究。采用高脂饲料制备大鼠AS模型,正常和AS模型大鼠口服给予200 mg·kg-1 GA,于不同时间点取血,分离血浆,蛋白沉淀法处理样品后,采用UPLC-MS/MS测定正常组和模型组大鼠血浆中槲皮素、山柰酚、异鼠李素药物浓度,使用WinNonlin 8。2软件计算相关药代动力学参数。采用Western blot分析检测肝脏组织中CYP1A2、CYP3A4、CYP2C19、CYP2C9的表达,采用RT-PCR检测小肠绒毛中多药耐药基因1(multiple drug resistance 1,MDR1)在mRNA水平的表达。结果显示,模型组槲皮素、山柰酚和异鼠李素的Tmax分别为正常组的2。00、2。50(P<0。05)、2。53倍,Cmzx分别为正常组的 46。98%、77。09%、57。19%(均 P<0。01),t1/2 分别为正常组的 1。76(P<0。05)、1。10、2。81(P<0。01)倍。与正常组相比,AS 大鼠肝脏中CYP1A2与CYP2C19表达分别降低38%、35%(P<0。05),CYP3A4表达升高1。36倍(P<0。05),而CYP2C9表达无显著差异;AS大鼠小肠绒毛中MDR1 mRNA表达升高1。7倍(P<0。05)。综上所述,槲皮素、山柰酚和异鼠李素在AS大鼠中的口服吸收程度减少,吸收速度和体内代谢速度减慢,这可能与其小肠P-糖蛋白(P-glycoprotein,P-gp)的高表达以及肝脏组织中CYP1A2、CYP3A4、CYP2C19 表达改变有关。
Pharmacokinetic differences and related mechanisms of ginkgo flavone aglycone in normal and atherosclerotic rats in vivo
This study aimed to compare the pharmacokinetics of ginkgo flavone aglycone(GA)in plasma after oral administration of GA in normal and atherosclerosis(AS)model rats and to explore the mechanism of pharmacokinetic differences.The AS rats were pre-pared by using high-fat diets.Rats in the normal and AS model groups were orally given 200 mg·kg-1 GA,blood samples were collected at different time points,plasma was separated,and the plasma concentrations of quercetin,kaempferol and isorhamnetin in the normal and AS model groups were determined by ultra-performance liquid chromatography-mass spectrometry(UPLC-MS/MS).The relevant pharmacokinetic parameters were calculated by WinNonlin 8.2 software.Western blot analysis was used to detect the expressions of CYP1A2,CYP3A4,CYP2C19 and CYP2C9 in liver tissue.Fluorescent quantitative real-time polymerase chain reaction(RT-PCR)was used to detect the expression of multiple drug resistance 1(MDR1)gene at mRNA level in intestinal villi.The Tmax of quercetin,kaempferol and isorhamnetin in the AS model group was 2.00,2.50(P<0.05)and 2.53 times that in the normal group,respectively,and the Cmax was 46.98%,77.09%and 57.19%of that in the normal group(P<0.01).The t1/2 of quercetin,kaempferol and isorha-mnetin in the model group was 1.76(P<0.05),1.10 and 2.81(P<0.01)times those in the normal group,respectively.Compared with those in the normal group,the expressions of CYP1A2 and CYP2C19 in the liver of AS rats were decreased by 38%and 35%,re-spectively(P<0.05),and the expression of CYP3A4 was increased by 1.36 times(P<0.05),while the expression of CYP2C9 was not significantly different.The messenger RNA(mRNA)expression of MDR1 in intestinal villi of AS rats was increased by 1.7 times(P<0.05).In conclusion,the oral absorption of quercetin,kaempferol and isorhamnetin in AS rats was reduced,with slower absorp-tion and metabolism rate in vivo,which might result from the high expression of P-glycoprotein(P-gp)in the small intestine and the al-tered expressions of CYP1A2,CYP3A4 and CYP2C19 in liver tissue.

ginkgo flavone aglyconeatherosclerosispharmacokineticsCYP450sP-gp

李琴、陈星懿、陆苑、陈际宇、陈丽华、宋忠军、李勇军、何艳

展开 >

贵州医科大学附属医院药物临床试验机构办公室,贵州 贵阳 550001

遵义医科大学基础药理教育部重点实验室,贵州遵义 563006

贵州医科大学药学院,贵州贵阳 550004

贵州医科大学贵州省药物制剂重点实验室省部共建药用植物功效与利用国家重点实验室,贵州贵阳 550004

贵州医科大学民族药与中药开发应用教育部工程研究中心,贵州贵阳 550004

展开 >

银杏黄酮苷元 动脉粥样硬化 药代动力学 CYP450s P-gp

基础药理教育部重点实验室项目贵州省科技计划项目贵州省科技计划项目贵州医科大学国家自然科学基金培育项目贵州医科大学国家自然科学基金培育项目贵州医科大学附属医院国家自然科学基金培育项目贵州省中医药管理局项目

黔教合KY字[2022]395号黔科合基础-ZK[2022]一般374黔科合基础-ZK[2023]一般37119NSP05621NSFCP13GYFYNSFC-2021-55QZYY-2018-130

2024

中国中药杂志
中国药学会

中国中药杂志

CSTPCD北大核心
影响因子:1.718
ISSN:1001-5302
年,卷(期):2024.49(18)